ReviewLasers in medical science2025
Bibliometric analysis of magnetic resonance imaging-ultrasound fusion in prostate biopsy: trends and collaborations (2000-2024).
Review in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Magnetic Resonance Imaging-Transrectal Ultrasound (MR/TRUS) fusion technology has markedly enhanced the accuracy of prostate biopsies. However, uncertainty persists regarding the standardization and widespread clinical adoption of MR/TRUS. This study presents a comprehensive bibliometric analysis of MR/TRUS prostate biopsy research from 2002 to 2024. A systematic search of the Web of Science Core Collection (WoSCC) was conducted, focusing on English-language research articles published between 2002 and 2024. Bibliometric tools, including VOSviewer (version 1.6.20), CiteSpace (version 6.3.R1), and R 4.3.3, were used to visualize collaboration networks, identify research trends, and analyze keyword co-occurrence. A total of 151 articles from 26 countries, authored by 1,012 researchers and affiliated with 63 institutions, were included in the analysis. The United States led with the highest number of publications (TP = 309) and citations (TC = 3,634), followed by Germany and China. The most influential journals were European Urology, Journal of Urology, and BJU International. Keyword analysis revealed that “prostate cancer,” “targeted biopsy,” and “image-guided biopsy” were central research themes. Collaborative network analysis demonstrated robust international cooperation, with 17.88% of publications involving international co-authorship. The field of MR/TRUS-fusion-targeted prostate biopsy has exhibited consistent growth and increasing international collaboration, with a pronounced focus on improving diagnostic accuracy. According to recent literature, future research is expected to emphasize the integration of artificial intelligence for lesion detection and the use of genetic profiling to guide personalized prostate cancer management. These directions, discussed within the manuscript, may help address current challenges in standardization and expand access to advanced diagnostics, especially in resource-limited settings.
Indexed as
Identifiers
41116134What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.